37 CFR Appendix G to Subpart G of Part 1: Appendix G to Subpart G of Part 1—Numeric Identifiers

Numeric identifier Definition Comments and format Mandatory (M) or optional (O)

<110> Applicant If Applicant is inventor, then preferably max. of 10 names; one name per line; preferable format: Surname, Other Names and/or Initials M.

<120> Title of Invention M.

<130> File Reference Personal file reference M when filed prior to assignment or appl. number.

<140> Current Application Number Specify as: US 09/999,999 or PCT/US09/99999 M, if available.

<141> Current Filing Date Specify as: yyyy-mm-dd M, if available.

<150> Prior Application Number Specify as: US 09/999,999 or PCT/US09/99999 M, if applicable include priority documents under 35 U.S.C. 119 and 120.

<151> Prior Application Filing Date Specify as: yyyy-mm-dd M, if applicable.

<160> Number of SEQ ID NOs Count includes total number of SEQ ID NOs M.

<170> Software Name of software used to create the “Sequence Listing” O.

<210> SEQ ID NO:#: Response shall be an integer representing the SEQ ID NO shown M.

<211> Length Respond with an integer expressing the number of bases or amino acid residues M.

<212> Type Whether presented sequence molecule is DNA, RNA, or PRT (protein). If a nucleotide sequence contains both DNA and RNA fragments, the type shall be “DNA.” In addition, the combined DNA/RNA molecule shall be further described in the <220> to <223> feature section M.

<213> Organism Scientific name, i.e., Genus/species, Unknown or Artificial Sequence. In addition, the “Unknown” or “Artificial Sequence” organisms shall be further described in the <220> to <223> feature section M.

<220> Feature Leave blank after <220>. <221-223> provide for a description of points of biological significance in the sequence M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence; if ORGANISM is “Artificial Sequence” or “Unknown”; if molecule is combined DNA/RNA.

<221> Name/Key Provide appropriate identifier for feature, from WIPO Standard ST.25 (2009), Appendices E and F to this subpart M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence.

<222> Location Specify location within sequence; where appropriate, state number of first and last bases/amino acids in feature M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence.

<223> Other Information Other relevant information; four lines maximum M, under the following conditions: If “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence; if ORGANISM is “Artificial Sequence” or “Unknown”; if molecule is combined DNA/RNA.

<300> Publication Information Leave blank after <30> O.

<301> Authors Preferably max. of 10 named authors of publication; specify one name per line; preferable format: Surname, Other Names and/or Initials O.

<302> Title O.

<303> Journal O.

<304> Volume O.

<305> Issue O.

<306> Pages O.

<307> Date Journal date on which data published; specify as yyyy-mm-dd, MMM-yyyy or Season-yyyy O.

<308> Database Accession Number Accession number assigned by database, including database name O.

<309> Database Entry Date Date of entry in database; specify as yyyy-mm-dd or MMM-yyyy O.

<310> Patent Document Number Document number; for patent-type citations only. Specify as, for example, US 09/999,999 O.

<311> Patent Filing Date Document filing date, for patent-type citations only; specify as yyyy-mm-dd O.

<312> Publication Date Document publication date, for patent-type citations only; specify as yyyy-mm-dd O.

<313> Relevant Residues FROM (position) TO (position) O.

<400> Sequence SEQ ID NO should follow the numeric identifier and should appear on the line preceding the actual sequence M.